FTC Probe into Big Pharma Sparks Drug Price Surge

Health-care companies are rallying amid expectations of higher drug prices and ongoing pharmaceutical shortages in the US. The FTC is investigating the role of companies in purchasing and distributing medicines, which could have implications for the industry. Market experts are closely monitoring the situation.